Why has this Alzheimer’s drug not been approved?

Lunchtime Live Highlights

Andrea Gilligan invites callers to have their say on the topics of the day - get in touch by emailing [email protected] Listen and subscribe to Lunchtime Live Highlights on Apple Podcasts and Spotify. Download, listen and subscribe on the Newstalk App. You can also listen to Newstalk live on newstalk.com or on Alexa, by and asking: 'Alexa, play Newstalk'

Why has this Alzheimer’s drug not been approved?

A drug designed to slow down cognitive decline in Alzheimer’s, Kisunla, has so far been turned down for approval by the EU. This has led to huge frustration amongst Alzheimer’s experts that hailed the drug as a game-changer. Joining guest host Anna Daly to discuss is Dr. Laura O’Philbin, Research and Policy Manager at the Alzheimer Society of Ireland, Professor Sean Kennelly, Clinical Director of the Institute of Memory and Cognition in Tallaght University Hospital and listeners who have been personally impacted by the disease. Image: Eli Lilly

Podcasts

Lunchtime Live Highlights

Latest episodes

Ask the GP with Dr John Flanagan

How to pick the best coffee machine for your home

Irish couple win £300k in Tattle Life legal case

Irishman on joining the ‘March to Gaza’

Will tourism protests throw you off going abroad?

The Pod Squad: The Reserve Drivers

Why has this Alzheimer’s drug not been approved?